Aquesta setmana, a l'IDIBAPS...
El projecte europeu #IGNITION, coordinat des de #IDIBAPS, tanca la seva convocatòria amb una destacada resposta internacional
560 candidatures de 64 països opten a les 13 places de doctorat
👉https://t.co/cTH7GUI9GO
Oberta la selecció de doctorands en neuroimmunologia i neurodegeneració del projecte #IGNITION
✔️13 contractes predoctorals de 36 mesos (2 al #IDIBAPS)
✔️Completament finançats per #MSCA
✔️Data límit 01/04
👉https://t.co/v0hgjV8gNo
@josemariacm_ , de nuestra unidad, cierra el curso presentando los resultados del estudio Neuro-CART-Spain, sobre ICANS asociado a terapia CAR T anti-CD19 en España.
Calor, tacte i dolor: com ho detecten les nostres neurones?
Cicle de xerrades divulgatives 'A la recerca de la salut'
👨🔬Xavier Gasull
📆17/3
⏰ 11:00
📍 Casa Golferichs @ccgolferichs
👉https://t.co/neD2iuvvNo
We’re now on Bluesky!
You will find:
🔬 EU-funded science news & breakthroughs
💰 Calls, tenders & funding tips (Horizon Europe, ERC, MSCA…)
🚀 Projects growing from TRL 1 to market-ready
📊 Tools & resources for researchers
Join the conversation: https://t.co/3iWGxaMjv8
Honored to present Dr. Frank Leypoldt as our keynote on #AutoimmuneEncephalitis — a rare chance to hear a world-class neuroimmunologist & GENERATE leader. Inspiring insights on LGI1, IgLON5 & future therapies. 🔗 👉 https://t.co/Yab05La8N3 Subscribe & hit the bell! #Neurology
Honored to present Dr. Frank Leypoldt as our keynote on #AutoimmuneEncephalitis — a rare chance to hear a world-class neuroimmunologist & GENERATE leader. Inspiring insights on LGI1, IgLON5 & future therapies. 🔗 👉 https://t.co/Yab05La8N3 Subscribe & hit the bell! #Neurology
Let me explain IGNITION consortium's logo: Two hemispheres of the #brain 🧠.
One 🚀 IGNITION rocket-antibodies against @iglon5
The other half, containing neurodegeneration. Let's solve this mistery together🔎. Apply for the #PhDposition fully funded by EU #MSCA-DN actions
Have you hear about IGNITION and anti-IgLON5 disease? @iglon5.
We have a web https://t.co/nHyrlMgZNU
We have a linkedin page
https://t.co/uc0i2BN0Uy
If you want a successful #career and a #PhD#PhDposition, then apply!. We need you in our
#MSCA consortium
🚀🔥🧠👩🎓👨🎓🌍
An intriguing point about IgLON5! The correlation between IgG4 antibodies and tau pathology is a compelling area of research, especially with the ability to replicate in vitro. What implications could this have for early diagnostic markers or therapeutic targets? It’s fascinating to see how these molecular interactions could redefine our understanding of neurodegenerative disease progression. For more on this topic, Sci-Quest is an excellent resource for generating comprehensive biomedical reviews. Check it out [here](https://t.co/4Y9Imt8uIJ) for more insights. #Neurology #Medicine
IgLON5 in 10 years: from disease discovery to mechanism🤯
This study in @Brain1878 suggests that even IgG4 anti-IgLON5 may come before “typical” tau, nuclear pSer422-tau is already detectable, with nuclear abnormalities reproduced by adding IgLON5 Abs to neurons in vitro!
@EU_Commission@hospitalclinic 🆕Se inicia el proceso de selección de doctorandos en neuroinmunología y neurodegeneración del proyecto #IGNITION
✔️13 contratos predoctorales de 36 meses (2 en #IDIBAPS)
✔️Completamente financiados por #MSCA
✔️Fecha límite 01/04
👉https://t.co/bp3rAWXHaf
@EU_Commission@hospitalclinic 🆕S’inicia el procés de selecció de doctorands en neuroimmunologia i neurodegeneració del projecte #IGNITION
✔️13 contractes predoctorals de 36 mesos (2 al #IDIBAPS)
✔️Completament finançats per #MSCA
✔️Data límit 01/04
👉https://t.co/VgdxNDZygv